Major Lipids and Future Risk of Pneumonia: 20 year Observation of the Atherosclerosis Risk in Communities (ARIC) Study Cohort.

[1]  Deepak L. Bhatt,et al.  Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia , 2019, The New England journal of medicine.

[2]  B. Nordestgaard,et al.  U-shaped relationship of HDL and risk of infectious disease: two prospective population-based cohort studies , 2018, European heart journal.

[3]  J. Coresh,et al.  CKD and Risk for Hospitalization With Infection: The Atherosclerosis Risk in Communities (ARIC) Study. , 2017, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[4]  J. Pellejà,et al.  HDL-c levels predict the presence of pleural effusion and the clinical outcome of community-acquired pneumonia , 2016, SpringerPlus.

[5]  A. Tenenbaum,et al.  Elevated Triglyceride Level Is Independently Associated With Increased All-Cause Mortality in Patients With Established Coronary Heart Disease: Twenty-Two–Year Follow-Up of the Bezafibrate Infarction Prevention Study and Registry , 2016, Circulation. Cardiovascular quality and outcomes.

[6]  D. Sviridov,et al.  High-density lipoprotein mimetics: promises and challenges. , 2015, The Biochemical journal.

[7]  Chong-Jen Yu,et al.  Decreased serum level of lipoprotein cholesterol is a poor prognostic factor for patients with severe community-acquired pneumonia that required intensive care unit admission. , 2015, Journal of critical care.

[8]  Mel S. Lee,et al.  Serum levels of apolipoprotein A-I and high-density lipoprotein can predict organ failure in acute pancreatitis , 2015, Critical Care.

[9]  G. Norata,et al.  HDL in innate and adaptive immunity. , 2014, Cardiovascular research.

[10]  Henry E. Wang,et al.  High-Sensitivity C-Reactive Protein and Risk of Sepsis , 2013, PloS one.

[11]  D. Prefasi,et al.  High-Density Lipoprotein: A Novel Marker for Risk of In-Hospital Infection in Acute Ischemic Stroke Patients? , 2013, Cerebrovascular Diseases.

[12]  Harold I Feldman,et al.  Estimating glomerular filtration rate from serum creatinine and cystatin C. , 2012, The New England journal of medicine.

[13]  Feng Su,et al.  Dysfunctional high-density lipoprotein and the potential of apolipoprotein A-1 mimetic peptides to normalize the composition and function of lipoproteins. , 2011, Circulation journal : official journal of the Japanese Circulation Society.

[14]  T. Matsuo,et al.  Lipoproteins and CETP levels as risk factors for severe sepsis in hospitalized patients , 2010, European journal of clinical investigation.

[15]  Runlin Han,et al.  Plasma lipoproteins are important components of the immune system , 2009, Microbiology and immunology.

[16]  G. Schmitz,et al.  Changes in HDL-associated apolipoproteins relate to mortality in human sepsis and correlate to monocyte and platelet activation , 2009, Intensive Care Medicine.

[17]  Mirjam Christ-Crain,et al.  Prognostic impact of plasma lipids in patients with lower respiratory tract infections - an observational study. , 2009, Swiss medical weekly.

[18]  D. Sviridov,et al.  The anti inflammatory effects of high density lipoproteins. , 2009, Current medicinal chemistry.

[19]  M. Boaz,et al.  Low HDL levels and the risk of death, sepsis and malignancy , 2008, Clinical Research in Cardiology.

[20]  Sina A. Gharib,et al.  Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL. , 2007, The Journal of clinical investigation.

[21]  E. Çakır,et al.  Serum total cholesterol, HDL-C and LDL-C concentrations significantly correlate with the radiological extent of disease and the degree of smear positivity in patients with pulmonary tuberculosis. , 2007, Clinical biochemistry.

[22]  E. Çakır,et al.  Serum HDL-C levels, log (TG/HDL-C) values and serum total cholesterol/HDL-C ratios significantly correlate with radiological extent of disease in patients with community-acquired pneumonia. , 2006, Clinical biochemistry.

[23]  H. Harris,et al.  Triglyceride-rich lipoproteins as agents of innate immunity. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[24]  Pan‐Chyr Yang,et al.  Low serum level of high-density lipoprotein cholesterol is a poor prognostic factor for severe sepsis* , 2005, Critical care medicine.

[25]  G. Anantharamaiah,et al.  The role of high-density lipoprotein in inflammation. , 2005, Trends in cardiovascular medicine.

[26]  S. Yusuf,et al.  Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study , 2004, The Lancet.

[27]  Kenneth R Feingold,et al.  Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. , 2004, Journal of lipid research.

[28]  J. Verhoef,et al.  Lipoprotein metabolism in patients with severe sepsis , 2003, Critical care medicine.

[29]  R. Morton,et al.  LDL and HDL enriched in triglyceride promote abnormal cholesterol transport DOI 10.1194/jlr.M100431-JLR200 , 2002, Journal of Lipid Research.

[30]  F. Giuliante,et al.  Pathophysiologic correlates of hypocholesterolemia in critically ill surgical patients , 1999, Intensive Care Medicine.

[31]  A. Gaetano,et al.  Hypocholesterolemia and risk of death in the critically ill surgical patient , 1996, Intensive Care Medicine.

[32]  P. Barie,et al.  Low lipid concentrations in critical illness: implications for preventing and treating endotoxemia. , 1996, Critical care medicine.

[33]  Aric Invest.  The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators , 1989 .

[34]  A. Folsom,et al.  The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. , 1989, American journal of epidemiology.

[35]  M. Taskinen,et al.  Changes in serum lipoprotein pattern induced by acute infections. , 1988, Metabolism: clinical and experimental.

[36]  P. Fu,et al.  Enzymatic determination of total serum cholesterol. , 1974, Clinical chemistry.

[37]  G Bucolo,et al.  Quantitative determination of serum triglycerides by the use of enzymes. , 1973, Clinical chemistry.

[38]  J. Gallin,et al.  Serum lipids in infection. , 1969, The New England journal of medicine.

[39]  G. Norata,et al.  Emerging role of high density lipoproteins as a player in the immune system. , 2012, Atherosclerosis.

[40]  S. Forman,et al.  Fitting Cox Model Using PROC PHREG and Beyond in SAS , 2009 .

[41]  J. Mosquera,et al.  Variation in Plasma Lipid and Lipoprotein Concentrations in Community-Acquired Pneumonia. A Six-Month Prospective Study , 1996, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.

[42]  N. Tietz,et al.  Textbook of clinical chemistry , 1986 .